EDITOR: | July 15th, 2020

Newly listed Perimeter Medical Imaging’s Andrew Berkeley on reducing the amount of repeat surgeries for cancer patients

| July 15, 2020 | No Comments
image_pdfimage_print

“The holy grail for medical technologies is to improve patient care and to reduce cost to the healthcare system. That’s where Perimeter is entirely focused on. Our technology is aimed at giving surgeons the ability to remove cancer tumors during procedures more successfully and that reduces the amount of repeat surgeries for cancer patients. This in turn will reduce the cost to the payer who has to pay for these unnecessary operations.” States Andrew Berkeley, Business Development and Founder of Perimeter Medical Imaging AI, Inc. (TSXV: PINK), in an interview with InvestorIntel’s Tracy Weslosky.

Andrew went on to say that Perimeter’s trading symbol is PINK which references their passion in solving a very big problem in breast cancer which is the unnecessary and unwanted amount of repeat surgeries. He continued, “about one in four women who had breast cancer surgery will return to the operating room for a second surgery. We hope that using our imaging device and eventually with our AI component we will be able to drastically reduce the amount of unnecessary second operations”

In the interview Andrew provided an update on the receipt of a US$7.44 million grant from CPRIT, a leading state body funding cancer research. He said, “The grant is to fund the development of the AI platform. We will be working with the leading physicians and sites in the state of Texas to gather the data to train our algorithms and also to test the algorithm in a multi-site clinical trial”

To access the complete interview, click here

Disclaimer: Perimeter Medical Imaging AI, Inc. is an advertorial member of InvestorIntel Corp.


Raj Shah

Editor:

Raj Shah has professional experience working for over a half a dozen years at financial firms such as Merrill Lynch and First Allied Securities Inc., ... <Read more about Raj Shah>


Copyright © 2020 InvestorIntel Corp. All rights reserved. More & Disclaimer »


Leave a Reply

Your email address will not be published. Required fields are marked *